Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancers

Trial Profile

Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancers

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2015

At a glance

  • Drugs Letrozole (Primary) ; Antineoplastics
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2015 Planned number of patients changed from 100 to 70 as reported by University Hospital Medical Information Network - Japan record.
    • 20 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top